H. pylori decreases gastric mucin synthesis via inhibition of galactosyltransferase

Hepato-Gastroenterology

Volumn 50, Issue 53, 2003, Pages 1739-1742

  Tanaka, Shouichi ^a   Mizuno, Motowo ^a   Maga, Toshirou ^a   Yoshinaga, Fumiya ^a   Tomoda, Jun ^a   Nasu, Junichirou ^a   Okada, Hiroyuki ^a   Yokota, Kenji ^a   Oguma, Keiji ^a   Shiratori, Yasushi ^a   Tsuji, Takao ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Helicobacter pylori; Mucin; UDP galactosyltransferase

Indexed keywords

GALACTOSYLTRANSFERASE; STOMACH MUCIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ENZYME INHIBITION; FEMALE; HELICOBACTER PYLORI; HUMAN; MALE; PEPTIC ULCER; PRIORITY JOURNAL; PROTEIN SYNTHESIS; STOMACH EPITHELIUM; STOMACH MUCOSA;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GALACTOSYLTRANSFERASES; GASTRIC MUCIN; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED;

EID: 10744229089     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Blaser MJ: The bacteria behind ulcers. Sci Am 1996; 274:104-107.
2. Rauws EA, Tytgat GN: Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335:1233-1235.
3. Graham DY, Lew GM, Klein PD, Evans DG, Evans DJ, Jr., Saeed ZA, et al: Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 1992; 116:705-708.
4. Labenz J, Borsch G: Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection. Am J Gastroenterol 1994; 89:1785-1788.
5. Van der Hulst RW, Rauws EA, Koycu B, Keller JJ, Bruno MJ, Tijssen JG, et al: Prevention of ulcer recurrence after eradication of Helicobacter pylori: A prospective long-term follow-up study. Gastroenterology 1997; 113:1082-1086.
6. Slomiany BL, Bilski J, Sarosiek J, Murty VL, Dworkin B, VanHorn K, et al: Campylobacter pyloridis degrades mucin and undermines gastric mucosal integrity. Biochem Biophys Res Commun 1987; 144:307-314.
7. Kawano S, Tsujii M, Nagano K, Ogihara T, Tanimura H, Hayashi N, et al: Different effect of Helicobacter pylori on the human gastric antral and body mucosal intracellular mucin. Scand J Gastroenterol 1990; 25:997-1003.
8. Sarosiek J, Marshall BJ, Peura DA, Hoffman S, Feng T, McCallum RW: Gastroduodenal mucus gel thickness in patients with Helicobacter pylori: A method for assessment of biopsy specimens. Am J Gastroenterol 1991; 86:729-734.
9. Sidebotham RL, Batten JJ, Karim QN, Spencer J, Baron JH: Breakdown of gastric mucus in presence of Helicobacter pylori. J Clin Pathol 1991; 44:52-57.
10. Allen A, Garner A: Mucus and bicarbonate secretion in the stomach and their possible role in mucosal protection. Gut 1980; 21:249-262.
11. Pearson J, Allen A, Venables C: Gastric mucus: Isolation and polymeric structure of the undegraded glycoprotein: Its breakdown by pepsin. Gastroenterology 1980; 78:709-715.
12. Byrd JC, Yunker CK, Xu QS, Sternberg LR, Bresalier RS: Inhibition of gastric mucin synthesis by Helicobacter pylori. Gastroenterology 2000; 118:1072-1079.
13. Strous GJ, Kramer MF: Glycoprotein synthesis in gastric epithelial cells of the rat. Properties of microsomal glycoprotein glycosyltransferases. Biochim Biophys Acta 1976; 451:201-211.
14. Maga T, Mizuno M, Tanaka S, Yoshinaga F, Mikami Y, Kihara Y, et al: Assessment of udp-galactosyl-transferase activity in gastric mucosa of patients with chronic liver disease using an enzyme-linked peanut agglutinin binding assay. Digestion 1997; 58:389-395.
15. Kim YS, Perdomo J, Nordberg J: Glycoprotein biosynthesis in small intestinal mucosa. I. A study of glycosyl-transferases in microsomal subfractions. J Biol Chem 1971; 246:5466-5476.
16. Marshall BJ, McGechie DB, Rogers PA, Glancy RJ: Pyloric campylobacter infection and gastroduodenal disease. Med J Aust 1985; 142:439-444.
17. Byrd JC, Yan P, Sternberg L, Yunker CK, Scheiman JM, Bresalier RS: Aberrant expression of gland-type gastric mucin in the surface epithelium of Helicobacter pylori-infected patients. Gastroenterology 1997; 113:455-464.
18. Micots I, Augeron C, Laboisse CL, Muzeau F, Megraud F: Mucin exocytosis: A major target for Helicobacter pylori. J Clin Pathol 1993; 46:241-245.
19. Strous GJ, Dekker J: Mucin-type glycoproteins. Crit Rev Biochem Mol Biol 1992; 27:57-92.
20. Newton JL, Jordan N, Oliver L, Strugala V, Pearson J, James OF, et al: Helicobacter pylori in vivo causes structural changes in the adherent gastric mucus layer but barrier thickness is not compromised. Gut 1998; 43:470-475.
21. Tzouvelekis LS, Mentis AF, Makris AM, Spiliadis C, Blackwell C, Weir DM: In vitro binding of Helicobacter pylori to human gastric mucin. Infect Immun 1991; 59:4252-4254.
22. Piotrowski J, Slomiany A, Murty VL, Fekete Z, Slomiany BL: Inhibition of Helicobacter pylori colonization by sulfated gastric mucin. Biochem Int 1991; 24:749-756.
23. Kamisago S, Iwamori M, Tai T, Mitamura K, Yazaki Y, Sugano K: Role of sulfatides in adhesion of Helicobacter pylori to gastric cancer cells. Infect Immun 1996; 64:624-628.
24. Simon PM, Goode PL, Mobasseri A, Zopf D: Inhibition of Helicobacter pylori binding to gastrointestinal epithelial cells by sialic acid-containing oligosaccharides. Infect Immun 1997; 65:750-757.
25. Cover TL, Blaser MJ: Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem 1992; 267:10570-10575.
26. Slomiany BL, Liau YH, Lopez RA, Piotrowski J, Czajkowski A, Slomiany A: Effect of Helicobacter pylori lipopolysaccharide on the synthesis of sulfated gastric mucin. Biochem Int 1992; 27:687-697.
27. Kawano S, Tsujii M, Fusamoto H, Sato N, Kamada T: Chronic effect of intragastric ammonia on gastric mucosal structures in rats. Dig Dis Sci 1991; 36:33-38.